Pharma & Biotech
-
Research by Abington Biochemist Proves Crucial for Both COVID-19 Vaccines
Decades of mRNA research by Abington biochemist Dr. Katalin Karikó have proven to be crucial in the development of both COVID-19 vaccines, writes Dana Kennedy for the New York Post. Karikó, who immigrated to the United States from Hungary in 1985 and is the mother of Olympic gold medalist Susan Francia, spent four decades obsessively…
-
Plymouth Meeting-based Inovio’s Immunotherapy Startup Raises $10.4M in Private Stocks
Geneos Therapeutics, the cancer immunotherapy startup that is a spinoff of Plymouth Meeting-based Inovio, has managed to raise $10.4 million in a private stock sale, writes John George for the Philadelphia Business Journal. According to Niranjan Y. Sardesai, the company’s co-founder and CEO, the latest stock sale was an extension of the company’s previous Series…
-
Plymouth Meeting-based Inovio Waiting for FDA Approval to Start COVID-19 Vaccine Trials
Plymouth Meeting-based Inovio Pharmaceuticals is waiting for approval from the FDA to start the next stage of trials for its COVID-19 vaccine candidate, INO-4800, writes Queen Muse for the Philadelphia Magazine. In April, the biotech company quickly became one of the frontrunners among organizations working on a COVID-19 vaccine after its candidate entered the human…
-
CSL Behring’s Parent Company Named One of World’s Best Employers Fourth Consecutive Year
For the fourth year in a row, CSL Limited, the parent company of King of Prussia-based CSL Behring, has been named one of the best employers in the world by Forbes magazine. The list was compiled by Statista, which surveyed 160,000 full-time and part-time employees from nearly 60 countries who work for businesses that operate…
-
Wall Street Journal: Merck Lagging Behind in COVID-19 Vaccine Efforts
Merck, the pharmaceutical giant with substantial operations in Montgomery County, is lagging behind in the COVID-19 vaccine efforts because it wanted to focus on proven technologies, write Gregory Zuckerman and Jared S. Hopkins for The Wall Street Journal. When COVID-19 first emerged as a possible worldwide threat in mid-February, Merck executives and scientists took differing…
-
Ambler Company Developing Vaccine That Could Provide Long-Lasting COVID Immunity
Ambler-based MBF Therapeutics, an animal health company that develops gene-based vaccines for pets, is working on a vaccine that could provide a longer-lasting immunity to COVID-19, writes Queen Muse for Philadelphia Magazine. The company was started twelve years ago by Tom Tillett and Lorraine Keller, who wanted to make an impact in the study and…
-
“Mask Up & Drop Off” For Montco’s Drug Take Back Day Oct. 24
After having to cancel the April Drug Take Back Day due to the severity of the pandemic, 44 police departments/agencies across Montgomery County are ready to collect all unwanted, unneeded and expired medications as part of Drug Take Back Day, organized by the Montgomery County District Attorney’s Office and the Police Chiefs Association of Montgomery…
-
Pharma Industry Veteran Joins King of Prussia-based Discovery Labs as Its President and COO
Joerg Ahlgrimm, a former Baxter Healthcare executive, has joined King of Prussia based Discovery Labs as its president and chief operating officer, writes John George for the Philadelphia Business Journal. “With Joerg, we have added an industry titan with impeccable credentials to oversee our operations,” said developer Brian O’Neill, co-founder and executive chairman of Discovery…
-
King of Prussia-based CSL Behring Evaluating Experimental Drug for COVID-19
A group of companies including King of Prussia-based CSL Behring are currently testing an experimental treatment for COVID-19 derived from the convalescent plasma of recovered patients, write Joseph Walker and Jared S. Hopkins for The Wall Street Journal. The National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, is…
-
Co-Founder of The Discovery Labs in King of Prussia is One of Region’s Power Women 2020
Audrey Greenberg, co-founder of The Discovery Labs, a sprawling life sciences complex in King of Prussia, is one of the Philadelphia region’s Power Women 2020, writes Lisa Dukart for the Main Line Today. The Discovery Labs complex totals more than 1.6 million square feet and provides biotech startups with more than enough space to effectively…
-
FDA Places Clinical Hold on Plymouth Meeting’s Inovio’s COVID-19 Vaccine
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze for the Yahoo!News. The hold – which is applicable to the Phase 2 and 3 trials but not Phase 1 – is due to concerns the FDA has with the “Cellectra” device that has to…
-
Merck Enters Partnership With Seattle Genetics Valued Potentially at $4.3B
Merck, the pharmaceutical giant with significant operations in Montgomery County, has entered into a partnership with Seattle Genetics to collaborate on cancer therapies, writes John George for the Philadelphia Business Journal. The partnership is potentially valued at more than $4.3 billion. As part of the deal, Washington-based Seattle Genetics will receive an upfront payment of…
-
Hatboro-Horsham Seniors Completed Research That Will Be Used by Atrin Pharmaceuticals
Despite doing most of their internship over Zoom, rising Hatboro-Horsham seniors Sarah Shegogue and Allyson Suman have successfully completed research that will be used by Atrin Pharmaceuticals in the future, according to a staff report from the Montgomery News. The pair worked on research related to Wee-1, a kinase or enzyme that is involved in…
-
Pandemic Could Mark Turning Point for Plymouth-based Inovio’s DNA Vaccine Technology
The coronavirus pandemic could mark a turning point for DNA vaccine technology that has been three decades in the making and is currently being developed by Plymouth Meeting-based Inovio, writes Marie McCullough for The Philadelphia Inquirer. David B. Weiner, known as “the father of DNA vaccines” in scientific circles, co-founded Inovio and is also its…
-
Big and Small Local Biotech, Pharmaceutical Companies Working on COVID-19 Vaccine
A growing number of local pharmaceutical, biotech, and medical device companies are joining efforts to develop a COVID-19 vaccine, writes John George for the Philadelphia Business Journal. Plymouth Meeting-based Inovio is working with Wistar Institute in Philadelphia on a DNA-based vaccine candidate. This is now heading into late-stage clinical testing less than three months after…
-
King of Prussia-Based CSL Behring Uses AI Forecasting System to Find People with Rare Diseases
King of Prussia-based CSL Behring is using an AI forecasting system developed over the span of four months utilizing data from the previous five years to find people with rare diseases such as hemophilia, writes Karen Carey for the BioWorld. However, when COVID-19 hit, the company that focuses on therapies based on human plasma saw…
-
Montco Turns to Nutritional DNA Company for COVID-19 Testing, Cuts Turn Around Time for Results
Montgomery County has drastically reduced the time required to receive COVID-19 testing results by using a small diagnostic company that recently entered the nutritional DNA field, writes Jason Laughlin for The Philadelphia Inquirer. The equipment and tools Mako Medical Laboratories uses to test DNA for nutritional recommendations are also used to test for the coronavirus.…
-
Bala Cynwyd’s Larimar Therapeutics Progresses Toward Cure for Friedreich’s Ataxia
Despite the widespread freeze on clinical research due to the coronavirus pandemic, Bala Cynwyd-based Larimar Therapeutics is advancing clinical trials for Friedreich’s ataxia, a complex inherited rare disease that causes progressive nervous system damage and movement problems, writes Queen Muse for the Philadelphia Magazine. The disease affects around one in 50,000 people and currently there…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
